Tang Capital Management as of Sept. 30, 2019
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 12 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Odonate Therapeutics Ord | 62.7 | $366M | 14M | 26.03 | |
| Heron Therapeutics (HRTX) | 17.4 | $102M | 5.5M | 18.50 | |
| La Jolla Pharmaceuticl Com Par | 7.4 | $44M | 4.9M | 8.80 | |
| Rocket Pharmaceuticals (RCKT) | 5.9 | $35M | 3.0M | 11.65 | |
| Avrobio Ord (AVRO) | 2.0 | $12M | 829k | 14.12 | |
| Celgene Corporation | 1.9 | $11M | 112k | 99.30 | |
| Puma Biotechnology (PBYI) | 0.6 | $3.8M | 349k | 10.76 | |
| Nucana Plc american depositary shares | 0.6 | $3.6M | 500k | 7.24 | |
| G1 Therapeutics | 0.6 | $3.4M | 150k | 22.78 | |
| Prothena (PRTA) | 0.6 | $3.3M | 424k | 7.84 | |
| Iveric Bio | 0.1 | $672k | 600k | 1.12 | |
| Cellectar Biosciences | 0.1 | $471k | 236k | 2.00 |
